SERPINF2
SERPINF2 (serpin family F member 2), also known as alpha-2-antiplasmin, A2AP, API, alpha2AP, ALPHA-2-PI, AAP and PLI, is a secreted serine protease inhibitor of the serpin family. It is a major inhibitor of plasmin and so helps regulate the blood clotting pathway. Browse Assay Genie's current range of SERPINF2 research reagents below, or read on for the biology behind the target.
SERPINF2 is a serine protease inhibitor. Its major targets are plasmin and trypsin, but it also inactivates matriptase-3 (TMPRSS7) and chymotrypsin. Plasmin degrades fibrin and various other proteins, so by inhibiting it, alpha-2-antiplasmin has a major role in regulating the blood clotting pathway. The protein is secreted, consistent with its action on extracellular proteases.
The SERPINF2 gene encodes a member of the serpin family of serine protease inhibitors, and UniProt classifies the protein as belonging to the serpin family. HGNC places it in the serpin peptidase inhibitors gene group. Multiple transcript variants encoding different isoforms have been reported for this gene. The mouse ortholog is Serpinf2, which provides a route to studying the protein in animal models.
Mutations in the SERPINF2 gene result in alpha-2-plasmin inhibitor deficiency, which is characterised by severe hemorrhagic diathesis. This link between gene function and bleeding makes the protein a natural focus for work on fibrinolysis and coagulation. The gene's earlier names, such as serine (or cysteine) proteinase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2, reflect its place within the wider serpin clade F, and the many aliases in the literature, including A2AP and alpha2AP, are worth searching when reviewing prior work.
SERPINF2 is a major inhibitor of plasmin, which degrades fibrin, making it central to studies of how clots are broken down.
The protein has a major role in regulating the blood clotting pathway, so it is relevant to haemostasis research.
Mutations in SERPINF2 cause alpha-2-plasmin inhibitor deficiency, characterised by severe hemorrhagic diathesis.
As a serpin that also inactivates trypsin, chymotrypsin and matriptase-3, it informs work on serine protease inhibition.
SERPINF2 is a serine protease inhibitor whose major targets are plasmin and trypsin. It also inactivates matriptase-3/TMPRSS7 and chymotrypsin. By inhibiting plasmin, which degrades fibrin, it helps regulate the blood clotting pathway.
SERPINF2 is commonly called alpha-2-antiplasmin. Other aliases include API, ALPHA-2-PI, A2AP, AAP, alpha2AP and PLI. Multiple transcript variants encoding different isoforms have been found for the gene, so check the datasheet of any product for its validated reactivity.
Yes. Mutations in the SERPINF2 gene result in alpha-2-plasmin inhibitor deficiency, which is characterised by severe hemorrhagic diathesis. The mouse ortholog, Serpinf2, is available for comparative studies, but check the datasheet of any product for its validated reactivity.
Other serpins, plasmin pathway components and coagulation-related targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P08697; product specifications from Assay Genie datasheets.